Approvals/NMPA/Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

Approved

化学药品

Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

Unknown🇨🇳 National Medical Products Administration

Approval Id: 8lIReNpt75T
Approval Number: 国药准字HJ20250076
Generic Name: 沙美特罗替卡松吸入粉雾剂
Generic Name En: Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
Drug Type: 化学药品
Dosage Form: 吸入制剂
Strength: 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松250μg，递送剂量为昔萘酸沙美特罗47μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松231μg
Reg Date: 2025-06-24
Expired Date: 2030-06-23

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 24, 2025

Approval ID

8lIReNpt75T

Type

化学药品